HSCIC: Clinical Audit Service


Published on

Learn more about the Clinical Audit Service and how this supports better care.

This presentation was delivered at EHI Live 2013.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

HSCIC: Clinical Audit Service

  1. 1. Clinical Audit Service Supporting better care Julie Henderson: Acting Head of Clinical Analysis
  2. 2. Clinical Audit Development • Clinical Leadership and Engagement • Inclusive Approach - Patient and Carer representatives - AHPs and Care Team representatives • Audit Measurement - Existing standards? - Baseline and variability? - Indicator Development and Assurance
  3. 3. Clinical Audit Design • NICE Quality Standards • Professional and Clinical Standards • Information Standards • Data Standards • Statistical Standards
  4. 4. Clinical Audit Considerations • Mandated or not? • Considering the burden • How to present findings and feedback • Support for improvement activities • Re-auditing
  5. 5. Clinical Audit and Improving Quality • Audit Findings, Feedback and Recommendations • NICE Quality Standards • Outcomes Frameworks - NHS OF - CCG Outcomes Indicator Set • Regulation, Professional Validation and Inspection - CQC - Royal Colleges
  6. 6. Clinical Audit and Improving Quality • Local ownership – CCGs, Boards, Clinical Senates, Strategic Clinical Networks, Action Teams, Patient Groups, Health and Wellbeing Boards, Healthwatch etc • Transparency - Methodology - Findings - Recommendations - Outliers - Indicator Construction - Data
  7. 7. Case Study: National Diabetes Audit • Worlds largest clinical audit - over 2.4 million people with diabetes • 90 per cent of GP practices in England and Wales participate • Clinically led and patient focused • Assessment of full integrated diabetes patient care pathway from GP practices to hospitals • Links patient records from multiple sources • Measures care against NICE clinical guidelines and quality standards • Provides benchmarked practice specific and hospital specific reports • Identifies diabetes patients with multi-morbidities and increased cardio vascular risk • Provides clinical recommendations for quality improvements
  8. 8. What Aspects of Diabetes Care and Outcomes are Measured? GP care Patient Inpatient Care Mortality test results Outpatient care Cardiovascular Complications Pregnancy care Kidney disease
  9. 9. Who is Involved in the NDA? • The NDA is a fully collaborative clinical audit that brings together: - Patients - GPs - Diabetologists - Physicians - Nurses - Midwifes - Commissioners - Informaticians - Governance specialists - Analytical methodologists
  10. 10. What Reports are Available? • NDA publishes national, CCG and Trust reports and provides GPs with practice specific reports Reports contain • Compliance with NICE clinical guidelines and quality standards • Clinical recommendations for quality improvement • Benchmarked analysis • Increased risk of adverse outcomes and cardiovascular complications • Increased risk of mortality • Equity of care measures
  11. 11. Clinical Improvements NICE updated clinical guidelines in 2008 to recommend that people with diabetes have a urine albumin: creatinine ratio (ACR) test annually. Urine ACR test is used to detect and monitor kidney disease Early detection and treatment can prevent or delay the progression of chronic kidney disease (CKD), reduce or prevent the development of complications and reduce the risk of cardiovascular disease In 2010 the NDA reported that 65 per cent of people with diabetes were receiving the NICE recommended Urine ACR test. The NDA initiated a programme of communication and improvement to highlight these issues. In 2 years the percentage of people with diabetes receiving the test rose to 75 per cent This means that an additional 200,000 people with diabetes are receiving this test that identifies and monitors kidney disease
  12. 12. National Lung Cancer Audit Audit Finding: not enough patients with small cell lung cancer receive chemotherapy Recommendation: chemotherapy rates below 65 per cent for this group of patients should be reviewed West Suffolk NHS Trust This trust identified that patients were waiting too long for treatment and therefore the cancer was too advanced for chemotherapy An alert system was established to flag up patients with the very aggressive small cell lung cancer, which allowed fast track booking of oncology appointments
  13. 13. West Suffolk NHS Trust
  14. 14. West Suffolk NHS Trust The Trust then followed this up by assessing whether this reduction in waiting times meant that more patients were able to receive treatment before they deteriorated and became too ill for chemotherapy The treatment rates for Small Cell Lung Cancer were between 50 and 60 per cent prior to improvement activities Following the quality interventions this increased to over 70 per cent
  15. 15. To Find Out More About the HSCIC Follow us: Call us on: 0845 300 6016 Email us at enquiries@hscic.gov.uk @hscic @hscicmedia @hscicOpenData @HSCIC_LSP @EPSnhs @NHSSCR @NHSPathways @NHSereferral http://www.flickr.com/photos/hscic/ https://www.linkedin.com/company/health-and-social-care-information- centre http://www.slideshare.net/HSCIC https://www.youtube.com/user/HSCIC1